Question

Question Posted 08/31/22:
In ADNI protocol, the EXCLUSION CRITERIA include clinically significant abnormalities in TFTs (Thyroid Function Tests) that might interfere with the study. Could you provide detailed criteria about this?
Besides, as shown in LABDATA.csv, the thyroid function reflected by thyroid stimulating hormone(TSH) was tested in screening, may be in COVANCE company. Could you provide the detailed methods of test about TSH? It’s better to provide detailed methods of all measures in screening labs.
Response posted 09/09/22 by Mike Donohue:
Documentation on this TSH lab is available here: https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.Elecsys%20TSH.08443432501.V2.en.pdf

Response posted 09/19/22 by Mike Donohue:
Additional documentation has been posted here:
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Cystatin.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Homocysteine.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.A1CX3.0207559674190c513.V2.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.ALB2.0005166861190c701.V7.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.ALP2.0005166888190c701.V8.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.ALT.0005850797190c701.V8.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.AST.0005850819190c701.V8.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.BILT3.0205795419190c701.V9.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.CA2.0005168449190c701.V8.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.CHOL2.0005168538190c701.V12.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.CO2-L.0005446376191c701.V12.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.CREP2.0205168589190c701.V1.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.DBILI.0605975921190c701.V7.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.Elecsys%20TSH.08443432501.V2.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.Elecsys%20Vitamin%20B12%20II.07028121501.V3.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.GLUC3.0205168791190c701.V9.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.ISE%20indirect%20Na-K-Cl%20for%20Gen.2.0210825468001c503.V2.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Insert.TP2.0005171385190c701.V12.en.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/Roche%20COBAS%20UREAL.pdf
https://adni.bitbucket.io/reference/docs/ADNI3_URMC_LABDATA/xn-1000-brochure_mkt-10-1215_rev3.pdf
Go back to list of topics >
2024 Alzheimer’s Disease Neuroimaging Initiative
This website is funded by the Alzheimer’s Disease Neuroimaging Initiative